Monday, 2 June 2014

Anti-diabetic drug metformin slows aging and lengthens lifespan





Roundworms treated with metformin show very limited size loss and no wrinkling. Credit: Wouter De Haes


A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world's most widely used anti-diabetic drug, slows ageing and increases lifespan.


In experiments reported in the journal Proceedings of the National Academy of Sciences, the researchers tease out the mechanism behind 's age-slowing effects: the drug causes an increase in the number of toxic released in the cell and this, surprisingly, increases cell robustness and longevity in the long term.


Mitochondria – the energy factories in cells – generate tiny electric currents to provide the body's cells with energy. Highly reactive oxygen molecules are produced as a by-product of this process.


While these molecules are harmful because they can damage proteins and DNA and disrupt normal cell functioning, a small dose can actually do the cell good, say the researchers: "As long as the amount of harmful oxygen molecules released in the cell remains small, it has a positive long-term effect on the cell. Cells use the reactive oxygen particles to their advantage before they can do any damage," explains Wouter De Haes. "Metformin causes a slight increase in the number of harmful oxygen molecules. We found that this makes cells stronger and extends their healthy lifespan."


It was long thought that harmful reactive oxygen molecules were the very cause of ageing. The food and cosmetics industries are quick to emphasise the 'anti-ageing' qualities of products containing antioxidants, such as skin creams, fruit and vegetable juices, red wine and dark chocolate.


But while antioxidants do in fact neutralise harmful reactive oxygen molecules in the cell, they actually negate metformin's anti-ageing effects because the drug relies entirely on these molecules to work.


The researchers studied metformin's mechanism in the tiny roundworm Caenorhabditis elegans, an ideal species for studying ageing because it has a lifespan of only three weeks. "As they age, the worms get smaller, wrinkle up and become less mobile. But worms treated with metformin show very limited size loss and no wrinkling. They not only age slower, but they also stay healthier longer," says Wouter De Haes. "While we should be careful not to over-extrapolate our findings to humans, the study is promising as a foundation for future research."


Other studies in humans have shown that metformin suppresses some cancers and heart disease. Metformin could even be an effective drug for counteracting the general effects of ageing, say the researchers.



More information: Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2, PNAS, 2014. http://ift.tt/RYXn0Y


Medical Xpress on facebook

Related Stories


Mitochondrial process may predict lifespan of organisms


Feb 24, 2014



The complexity in biology is astounding. That is why biologists are thankful that model organisms, like the roundworm Caenorhabditis elegans, can be used to breakdown biological processes into simpler units. ...



Study reveals how diabetes drug delays ageing in worms


Mar 28, 2013



A widely prescribed type 2 diabetes drug slows down the ageing process by mimicking the effects of dieting, according to a study published today using worms to investigate how the drug works.



Damaged protein could be key to premature ageing


May 13, 2014



(Medical Xpress)—Scientists have found that the condition of key proteins in the mitochondria -the batteries of cells- could be used to predict, and eventually treat premature ageing. And restricting diet ...



Study questions anti-cancer mechanisms of drug tested in clinical trials


Jan 13, 2014



The diabetes drug metformin is also being tested in numerous clinical trials for treating different cancers, and several studies point to its apparent activation of a molecular regulator of cell metabolism called AMPK to ...



Fresh faced: Looking younger for longer


Jan 10, 2014



Newcastle University researchers have identified an antioxidant Tiron, which offers total protection against some types of sun damage and may ultimately help our skin stay looking younger for longer.



Recommended for you


'Healthy' component of red wine, resveratrol, causes pancreatic abnormalities in fetuses


3 hours ago



Here's more evidence that pregnant women should be careful about what they eat and drink: A new research report appearing in the June 2014 issue of The FASEB Journal shows that when taken during pregnancy, resveratrol supple ...



Why some experimental forms of 'The Pill for Males' will never rise to the occasion


5 hours ago



It appears that "The Pill" for men will have to wait a while longer. A new research report published in the June 2014 issue of The FASEB Journal involving mice, shows that a previously developed male hormonal oral contra ...





Cystic fibrosis and diabetes link explained


6 hours ago



Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism ...



Discovery of protein that regulates cellular recycling yields new drug targets


7 hours ago



Researchers at the University of Michigan have discovered a key regulator of autophagy, the cellular recycling process involved in many human diseases. The finding illuminates potential new drug targets for cancer, neurodegeneration ...



Paired enzyme action in yeast reveals backup system for DNA repair


Jun 01, 2014



The combined action of two enzymes, Srs2 and Exo1, prevents and repairs common genetic mutations in growing yeast cells, according to a new study led by scientists at NYU Langone Medical Center.



Coaxing iPS cells to become more specialized prior to transplantation cuts rejection risk


May 30, 2014



For many scientists, the clinical promise of stem cells has been dampened by very real concerns that the immune system will reject the transplanted cells before they could render any long-term benefit. Previous research in ...



User comments









Roundworms treated with metformin show very limited size loss and no wrinkling. Credit: Wouter De Haes


A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world's most widely used anti-diabetic drug, slows ageing and increases lifespan.


In experiments reported in the journal Proceedings of the National Academy of Sciences, the researchers tease out the mechanism behind 's age-slowing effects: the drug causes an increase in the number of toxic released in the cell and this, surprisingly, increases cell robustness and longevity in the long term.


Mitochondria – the energy factories in cells – generate tiny electric currents to provide the body's cells with energy. Highly reactive oxygen molecules are produced as a by-product of this process.


While these molecules are harmful because they can damage proteins and DNA and disrupt normal cell functioning, a small dose can actually do the cell good, say the researchers: "As long as the amount of harmful oxygen molecules released in the cell remains small, it has a positive long-term effect on the cell. Cells use the reactive oxygen particles to their advantage before they can do any damage," explains Wouter De Haes. "Metformin causes a slight increase in the number of harmful oxygen molecules. We found that this makes cells stronger and extends their healthy lifespan."


It was long thought that harmful reactive oxygen molecules were the very cause of ageing. The food and cosmetics industries are quick to emphasise the 'anti-ageing' qualities of products containing antioxidants, such as skin creams, fruit and vegetable juices, red wine and dark chocolate.


But while antioxidants do in fact neutralise harmful reactive oxygen molecules in the cell, they actually negate metformin's anti-ageing effects because the drug relies entirely on these molecules to work.


The researchers studied metformin's mechanism in the tiny roundworm Caenorhabditis elegans, an ideal species for studying ageing because it has a lifespan of only three weeks. "As they age, the worms get smaller, wrinkle up and become less mobile. But worms treated with metformin show very limited size loss and no wrinkling. They not only age slower, but they also stay healthier longer," says Wouter De Haes. "While we should be careful not to over-extrapolate our findings to humans, the study is promising as a foundation for future research."


Other studies in humans have shown that metformin suppresses some cancers and heart disease. Metformin could even be an effective drug for counteracting the general effects of ageing, say the researchers.



More information: Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2, PNAS, 2014. http://ift.tt/RYXn0Y


Medical Xpress on facebook

Related Stories


Mitochondrial process may predict lifespan of organisms


Feb 24, 2014



The complexity in biology is astounding. That is why biologists are thankful that model organisms, like the roundworm Caenorhabditis elegans, can be used to breakdown biological processes into simpler units. ...



Study reveals how diabetes drug delays ageing in worms


Mar 28, 2013



A widely prescribed type 2 diabetes drug slows down the ageing process by mimicking the effects of dieting, according to a study published today using worms to investigate how the drug works.



Damaged protein could be key to premature ageing


May 13, 2014



(Medical Xpress)—Scientists have found that the condition of key proteins in the mitochondria -the batteries of cells- could be used to predict, and eventually treat premature ageing. And restricting diet ...



Study questions anti-cancer mechanisms of drug tested in clinical trials


Jan 13, 2014



The diabetes drug metformin is also being tested in numerous clinical trials for treating different cancers, and several studies point to its apparent activation of a molecular regulator of cell metabolism called AMPK to ...



Fresh faced: Looking younger for longer


Jan 10, 2014



Newcastle University researchers have identified an antioxidant Tiron, which offers total protection against some types of sun damage and may ultimately help our skin stay looking younger for longer.



Recommended for you


'Healthy' component of red wine, resveratrol, causes pancreatic abnormalities in fetuses


3 hours ago



Here's more evidence that pregnant women should be careful about what they eat and drink: A new research report appearing in the June 2014 issue of The FASEB Journal shows that when taken during pregnancy, resveratrol supple ...



Why some experimental forms of 'The Pill for Males' will never rise to the occasion


5 hours ago



It appears that "The Pill" for men will have to wait a while longer. A new research report published in the June 2014 issue of The FASEB Journal involving mice, shows that a previously developed male hormonal oral contra ...





Cystic fibrosis and diabetes link explained


6 hours ago



Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism ...



Discovery of protein that regulates cellular recycling yields new drug targets


7 hours ago



Researchers at the University of Michigan have discovered a key regulator of autophagy, the cellular recycling process involved in many human diseases. The finding illuminates potential new drug targets for cancer, neurodegeneration ...



Paired enzyme action in yeast reveals backup system for DNA repair


Jun 01, 2014



The combined action of two enzymes, Srs2 and Exo1, prevents and repairs common genetic mutations in growing yeast cells, according to a new study led by scientists at NYU Langone Medical Center.



Coaxing iPS cells to become more specialized prior to transplantation cuts rejection risk


May 30, 2014



For many scientists, the clinical promise of stem cells has been dampened by very real concerns that the immune system will reject the transplanted cells before they could render any long-term benefit. Previous research in ...



User comments








Categories:

0 comments:

Post a Comment